Trade

with

MiMedx Group Inc
(NASDAQ: MDXG)
AdChoices
8.49
+0.11
+1.31%
After Hours :
-
-
-

Open

8.54

Previous Close

8.38

Volume (Avg)

30.23k (515.62k)

Day's Range

8.35-8.55

52Wk Range

4.88-9.00

Market Cap.

887.06M

Dividend Rate ( Yield )

-

Beta

0.04

Shares Outstanding

105.73M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Devices
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 59.18M

    • Net Income

    • -4.11M

    • Market Cap.

    • 887.06M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -3.84

    • PEG (Price/Earnings Growth) Ratio

    • 2.31

    • Beta

    • 0.04

    • Forward P/E

    • 29.59

    • Price/Sales

    • 10.78

    • Price/Book Value

    • 11.90

    • Price/Cash flow

    • 400.00

      • EBITDA

      • -947.35k

      • Return on Capital %

      • -4.82

      • Return on Equity %

      • -5.67

      • Return on Assets %

      • -4.82

      • Book Value/Share

      • 0.70

      • Shares Outstanding

      • 105.73M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/17/2014
      Buy
        • 1 Year Price Target

        • 11.50

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • 0.21

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 89.20

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -

          • -22.64

          • Net Income

            Q/Q (last year)

          • -

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 4.60

          • Net Income

            5-Year Annual Average

          • -

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 86.19

            • 64.08

            • Pre-Tax Margin

            • -3.78

            • 15.19

            • Net Profit Margin

            • -3.84

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.34

              • Current Ratio

              • 6.69

              • 2.55

              • Quick Ratio

              • 6.03

              • 1.83

              • Interest Coverage

              • -

              • 11.70

              • Leverage Ratio

              • 1.15

              • 1.86

              • Book Value/Share

              • 0.70

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -285.71

                • 33.33

                • P/E Ratio 5-Year High

                • -300.65

                • 224.03

                • P/E Ratio 5-Year Low

                • -17.37

                • 60.23

                • Price/Sales Ratio

                • 10.91

                • 3.11

                • Price/Book Value

                • 12.05

                • 3.14

                • Price/Cash Flow Ratio

                • 400.00

                • 18.08

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -5.67

                    (-)

                  • 12.33

                    (18.16)

                  • Return on Assets %

                    (5-Year Average)

                  • -4.82

                    (-)

                  • 6.62

                    (8.69)

                  • Return on Capital %

                    (5-Year Average)

                  • -5.67

                    (-)

                  • 8.49

                    (11.48)

                  • Income/Employee

                  • -

                  • 34.11k

                  • Inventory Turnover

                  • 2.59

                  • 2.77

                  • Asset Turnover

                  • 1.25

                  • 0.51

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -2.64M
                  Operating Margin
                  -4.46
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  400.00
                  Ownership

                  Institutional Ownership

                  41.22%

                  Top 10 Institutions

                  23.64%

                  Mutual Fund Ownership

                  17.06%

                  Float

                  88.03%

                  5% / Insider Ownership

                  13.77%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • JPM Global Healthcare

                  •  

                    2,940,479

                  • 0.00

                  • 2.78

                  • SPDR® S&P Biotech ETF

                  •  

                    1,553,723

                  • 0.60

                  • 1.71

                  • iShares Russell 2000 (AU)

                  •  

                    1,459,815

                  • -1.01

                  • 1.61

                  • Vanguard Total Stock Mkt Idx

                  •  

                    1,436,273

                  • 0.00

                  • 1.36

                  • MFS® New Discovery Fund

                  •  

                    1,306,718

                  • 0.12

                  • 1.24

                  • Fidelity® Select Biotechnology Portfolio

                  •  

                    1,006,364

                  • 0.00

                  • 0.95

                  • Vanguard Extended Market Index Fund

                  •  

                    754,123

                  • 2.62

                  • 0.71

                  • iShares Russell 2000 Growth

                  •  

                    688,609

                  • 0.77

                  • 0.76

                  • MFS® VIT New Discovery Series

                  •  

                    585,171

                  • 18.95

                  • 0.55

                  • American Beacon Stephens Sm Cp Gr Fund

                  •  

                    495,700

                  • 0.00

                  • 0.47

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • ADEC PRIVATE EQUITY INVESTMENTS LLC

                  •  

                    4,999,962

                  • -9.70%

                  • 5.08

                  • J P Morgan Asset Management (UK) Ltd

                  •  

                    2,941,135

                  • +44.40%

                  • 2.79

                  • MFS Investment Management K.K.

                  •  

                    2,808,172

                  • +6.85%

                  • 2.67

                  • State Street Corp

                  •  

                    2,681,880

                  • -28.89%

                  • 2.55

                  • Vanguard Group, Inc.

                  •  

                    2,593,699

                  • +6.20%

                  • 2.46

                  • Bt Alex Brown Inc

                  •  

                    2,202,712

                  • +74,140.38%

                  • 2.09

                  • BlackRock Fund Advisors

                  •  

                    2,058,821

                  • -9.45%

                  • 1.95

                  • Tamarack Capital Management, LLC

                  •  

                    1,775,000

                  • -1.39%

                  • 1.62

                  • Stephens Inv Mgmt Group LLC

                  •  

                    1,307,595

                  • +71.60%

                  • 1.24

                  • Fidelity Management and Research Company

                  •  

                    1,256,777

                  • -6.16%

                  • 1.19

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Devices

                  Type

                  Speculative Growth

                  Style

                  Small Growth

                  MiMedx Group, Inc. was incorporated in Florida on February 28, 2008. The Company develops clinical solutions for the use of its biomaterials to regenerate soft tissue in wound healing, orthopedics and other specialty fields of medici...morene. It is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and allografts processed from human amniotic membrane. Its biomaterial platform technologies include the device technologies HydroFix and CollaFixM, and its tissue technologies, AmnioFix and EpiFix. It is a supplier of allografts processed from amniotic tissue, having supplied approximately over 200,000 allografts to date for application in the Surgical, Orthopedic, Spinal, Wound Care, Ophthalmic, and Dental segments of healthcare. Its technology and product...mores are Purion, AmnioFix, EpiFix and other Tissue -Based Allografts and Medical Devices- CollaFix and HydroFix. The Company operates a licensed tissue bank. Its solutions are being used to treat chronic wounds, including diabetic foot ulcers, venous stasis ulcers, arterial ulcers and pressure ulcers, burns and surgical wounds.lessless

                  Key People

                  Parker H. (Pete) Petit

                  CEO/Chairman of the Board/Director

                  Mr. Michael J. Senken

                  CFO/Chief Accounting Officer

                  Charles E. Koob

                  Director

                  William C. Taylor

                  COO/Director/President

                  Charles R. Evans

                  Director

                  • MiMedx Group Inc

                  • 1775 West Oak Commons Court NE

                  • Marietta, GA 30062

                  • USA.Map

                  • Phone: +1 770 651-9100

                  • Fax: -

                  • mimedx.com

                  Incorporated

                  2000

                  Employees

                  222

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: